66 related articles for article (PubMed ID: 20418015)
1. Multidrug resistance in oral squamous cell carcinoma: The role of vacuolar ATPases.
Pérez-Sayáns M; Somoza-Martín JM; Barros-Angueira F; Diz PG; Rey JM; García-García A
Cancer Lett; 2010 Sep; 295(2):135-43. PubMed ID: 20418015
[TBL] [Abstract][Full Text] [Related]
2. With resistance for a reason.
Izmaylov M
Acad Emerg Med; 2023 Aug; 30(8):890. PubMed ID: 36587376
[No Abstract] [Full Text] [Related]
3. Increased V-ATPase activity can lead to chemo-resistance in oral squamous cell carcinoma via autophagy induction: new insights.
Lagzian A; Askari M; Haeri MS; Sheikhi N; Banihashemi S; Nabi-Afjadi M; Malekzadegan Y
Med Oncol; 2024 Apr; 41(5):108. PubMed ID: 38592406
[TBL] [Abstract][Full Text] [Related]
4. Organelle-targeted therapies: a comprehensive review on system design for enabling precision oncology.
Yang J; Griffin A; Qiang Z; Ren J
Signal Transduct Target Ther; 2022 Nov; 7(1):379. PubMed ID: 36402753
[TBL] [Abstract][Full Text] [Related]
5. Advances in antitumor research of CA-4 analogs carrying quinoline scaffold.
Wang C; Chang J; Yang S; Shi L; Zhang Y; Liu W; Meng J; Zeng J; Zhang R; Xing D
Front Chem; 2022; 10():1040333. PubMed ID: 36385996
[TBL] [Abstract][Full Text] [Related]
6. SNHG1/miR-145-5p/KLF5 Axis Participates in Regulating the Proliferation and Migration of Oral Squamous Cell Cancer.
Xin H; Feng Z; Yao C
J Healthc Eng; 2022; 2022():2053271. PubMed ID: 35281530
[TBL] [Abstract][Full Text] [Related]
7. Ginkgolide B Regulates CDDP Chemoresistance in Oral Cancer via the Platelet-Activating Factor Receptor Pathway.
Kawasaki K; Kasamatsu A; Ando T; Saito T; Nobuchi T; Nozaki R; Iyoda M; Uzawa K
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944919
[TBL] [Abstract][Full Text] [Related]
8. Research Progress on the Functions and Mechanism of circRNA in Cisplatin Resistance in Tumors.
Mu Q; Lv Y; Luo C; Liu X; Huang C; Xiu Y; Tang L
Front Pharmacol; 2021; 12():709324. PubMed ID: 34566636
[TBL] [Abstract][Full Text] [Related]
9. Exosomal-mediated transfer of APCDD1L-AS1 induces 5-fluorouracil resistance in oral squamous cell carcinoma via miR-1224-5p/nuclear receptor binding SET domain protein 2 (NSD2) axis.
Li S; Shi Z; Fu S; Li Q; Li B; Sang L; Wu D
Bioengineered; 2021 Dec; 12(1):7188-7204. PubMed ID: 34546854
[TBL] [Abstract][Full Text] [Related]
10. Extracellular Vesicle-Mediated Chemoresistance in Oral Squamous Cell Carcinoma.
Law ZJ; Khoo XH; Lim PT; Goh BH; Ming LC; Lee WL; Goh HP
Front Mol Biosci; 2021; 8():629888. PubMed ID: 33768115
[TBL] [Abstract][Full Text] [Related]
11. Altered glycolysis results in drug-resistant in clinical tumor therapy.
Peng J; Cui Y; Xu S; Wu X; Huang Y; Zhou W; Wang S; Fu Z; Xie H
Oncol Lett; 2021 May; 21(5):369. PubMed ID: 33747225
[TBL] [Abstract][Full Text] [Related]
12. LncRNA FER1L4 Promotes Oral Squamous Cell Carcinoma Progression via Targeting miR-133a-5p/Prx1 Axis.
Zhang N; Zeng L; Wang S; Wang R; Yang R; Jin Z; Tao H
Onco Targets Ther; 2021; 14():795-806. PubMed ID: 33568918
[TBL] [Abstract][Full Text] [Related]
13. Stimuli-responsive drug delivery systems for head and neck cancer therapy.
Liang J; Yang B; Zhou X; Han Q; Zou J; Cheng L
Drug Deliv; 2021 Dec; 28(1):272-284. PubMed ID: 33501883
[TBL] [Abstract][Full Text] [Related]
14. Loss of Tumor Suppressor CYLD Expression Triggers Cisplatin Resistance in Oral Squamous Cell Carcinoma.
Suenaga N; Kuramitsu M; Komure K; Kanemaru A; Takano K; Ozeki K; Nishimura Y; Yoshida R; Nakayama H; Shinriki S; Saito H; Jono H
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31635163
[TBL] [Abstract][Full Text] [Related]
15. Dissecting the Proton Transport Pathway in Oral Squamous Cell Carcinoma: State of the Art and Theranostics Implications.
Lorenzo-Pouso AI; Pérez-Sayáns M; Rodríguez-Zorrilla S; Chamorro-Petronacci C; García-García A
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31470498
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin-Resistance in Oral Squamous Cell Carcinoma: Regulation by Tumor Cell-Derived Extracellular Vesicles.
Khoo XH; Paterson IC; Goh BH; Lee WL
Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31416147
[TBL] [Abstract][Full Text] [Related]
17. Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo.
De Vera AA; Gupta P; Lei Z; Liao D; Narayanan S; Teng Q; Reznik SE; Chen ZS
Cancer Lett; 2019 Feb; 442():91-103. PubMed ID: 30391357
[TBL] [Abstract][Full Text] [Related]
18. Suppression of c-MET overcomes erlotinib resistance in tongue cancer cells.
Huang K; Liu D
Onco Targets Ther; 2018; 11():5499-5508. PubMed ID: 30233210
[TBL] [Abstract][Full Text] [Related]
19. Aspirin is Involved in the Cell Cycle Arrest, Apoptosis, Cell Migration, and Invasion of Oral Squamous Cell Carcinoma.
Zhang X; Feng H; Li Z; Guo J; Li M
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30002310
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
